Wall Street takes a blow after disappointing US jobs data
ADVERTISEMENT
ADVERTISEMENT
More about this topic
US panel rejects psychedelic drug MDMA as a PTSD treatment
MDMA, commonly known as molly, triggers feelings of intimacy, connection, and euphoria, but experts weren't convinced by the benefits of the drug for PTSD patients.
Remnants of bird flu virus found in pasteurised milk, US says
Although the virus is lethal to commercial poultry, most infected cattle seem to recover within two weeks, experts said.
Many cancer drugs remain unproven years after accelerated FDA approval
Some drugs remain unproven years after accelerated approval.
ALS drug removed from US market after trial shows it doesn't work
A pharmaceutical company announced its intention to remove a drug for ALS from the US and Canadian markets after a trial showed it did not work.
ADVERTISEMENT
Asthma medicine could help children with food allergies, study finds
A study highlighted the efficacy of an approved drug for allergic asthma, with nearly 70 per cent of participants showing better tolerance of food allergens.
New Alzheimer’s drug gets full approval from US regulators
The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months.
Prescription poo: US approves first faecal transplant therapy
The pharmaceutical-grade faecal transplant therapy aims to prevent recurrent and life-threatening gut infections.
Moderna seeks emergency approval for COVID vaccine in kids under 6
Moderna’s COVID vaccine is around 44 per cent effective for children aged 6 months to 2 years old, early clinical trial results show.
Pfizer's COVID vaccine can now be used on children aged 5-11 in the US
President Joe Biden hailed the move as a "turning point" in the fight against the pandemic.
Could COVID pills be a game-changer for vaccine equity?
A new antiviral pill that has been shown to treat COVID-19 in high-risk patients is seeking authorisation.
COVID pill 'cuts risk of death or hospitalisation by half,' says Merck
The company is to ask health officials in the US and around the world to authorise its use. If approved, it would be the first pill shown to treat COVID.
Breakthrough or hype? US approves much-debated new Alzheimer's drug
US health officials have approved the first drug that they say may help slow Alzheimer's disease. Many experts are unconvinced.